2025-04-22 - Analysis Report
## MicroStrategy Inc. (MSTR) Stock Review

**0) Summary of Key Figures:**

* **Cumulative Return (MSTR):** 1072.04%
* **Cumulative Return (VOO):** 72.42%
* **Return Difference:** 999.62%
* **Relative Divergence:** 52.5% (indicates MSTR's performance is in the upper 52.5th percentile relative to its historical performance compared to VOO)
* **Current Price:** $317.76
* **5-Day Moving Average:** $313.76
* **20-Day Moving Average:** $302.38
* **60-Day Moving Average:** $303.92
* **Market Risk Indicator (MRI):** 0.4082 (Medium Risk)
* **RSI:** 55.86
* **PPO:** 1.23
* **Expected Return (2+ years):** 147.3% (vs. S&P 500)


**1) Performance Comparison and Company Overview:**

MicroStrategy Inc. (MSTR) is a business intelligence company that provides software and services for enterprise analytics.  Over the period reviewed, MSTR significantly outperformed the S&P 500 (VOO), exhibiting a cumulative return of 1072.04% compared to VOO's 72.42%.  The substantial difference of 999.62% highlights MSTR's exceptional performance, although the relative divergence suggests this outperformance is partially driven by periods of extreme volatility and high risk.

The provided Alpha and Beta analysis reveals highly volatile performance.  While recent years (2022-2025) show extremely high CAGR, the earlier years depict significant negative returns and high maximum drawdown (MDD).  High Beta values (often above 3) indicate significant sensitivity to market movements.


**2) Recent Price Movement:**

The current price of MSTR is $317.76, slightly above its 5-day moving average ($313.76) and considerably higher than both its 20-day ($302.38) and 60-day ($303.92) moving averages. This suggests a recent upward trend. The small positive change of $0.18 from the previous close does not indicate a significant price jump or drop.


**3) Technical Indicators and Expected Return:**

The RSI of 55.86 suggests the stock is neither overbought nor oversold, indicating a neutral momentum.  A positive PPO value of 1.23 points towards a bullish trend. The recent positive change in relative divergence (+1.0) confirms a short-term upward momentum. The MRI of 0.4082 suggests a medium level of risk.  A projected long-term (2+ years) expected return of 147.3% exceeding the S&P 500 significantly, but this should be considered with caution given the high risk profile indicated by historical data.


**4) Recent Earnings Analysis:**

| Date       | EPS       | Revenue      |
|------------|-----------|-------------|
| 2024-10-31 | -1.72      | $0.12 B     |
| 2024-08-06 | -5.74      | $0.11 B     |
| 2024-05-01 | -3.09      | $0.12 B     |
| 2023-11-01 | -10.09     | $0.13 B     |
| 2024-10-31 | -1.01      | $0.13 B     | *(Duplicate date, likely an error)*


The recent earnings show significant losses (negative EPS).  Revenue remains relatively stable but low.  Inconsistency in the data (duplicate date) raises concerns about data reliability. Further investigation into the source and accuracy of this data is crucial.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $0.12B | 71.69%       |
| 2024-09-30 | $0.12B | 70.41%       |
| 2024-06-30 | $0.11B | 72.24%       |
| 2024-03-31 | $0.12B | 73.96%       |
| 2023-12-31 | $0.12B | 77.33%       |

**Capital and Profitability:**

| Quarter | Equity     | ROE         |
|---------|------------|-------------|
| 2024-12-31 | $18.23B    | -3.68%      |
| 2024-09-30 | $3.77B     | -9.01%      |
| 2024-06-30 | $2.83B     | -3.62%      |
| 2024-03-31 | $2.40B     | -2.21%      |
| 2023-12-31 | $2.16B     | 4.12%       |


Revenue is relatively stable, while profit margins are consistently high. However, the Return on Equity (ROE) is largely negative, indicating a low return on invested capital. The substantial fluctuation in equity from quarter to quarter needs further investigation.


**6) Overall Analysis:**

MSTR has shown extraordinary returns compared to the S&P 500, but this performance is characterized by significant volatility and high risk.  The high Beta and past negative returns highlight this inherent risk. While recent price action is positive, and technical indicators are neutral to bullish, the negative EPS and fluctuating ROE raise serious concerns about the company's financial health.  The large disparity between the high cumulative return and the negative recent earnings needs further investigation.  Before making any investment decisions, it's crucial to thoroughly investigate the reasons behind the high returns and address the inconsistencies and negative aspects of the financial data presented.  The high expected return projection should be treated with caution, considering the inherent risks and volatility associated with MSTR.  Further due diligence is strongly recommended.
